Clinical Trials Research | Sacramento, CA

Research site

(Unclaimed)

Location

3750 Auburn Boulevard, Suite A, Sacramento, California, United States of America

Site insights

Top conditions

Top treatments

Tanezumab

ALT-801

Ramipril

fezolinetant

Estetrol

TVB 2640

PF-06865571

MK-6024-013

Donanemab

Polypill

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 20 total trials

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) (AMARONE)

EYE103-101 is a 2-part study assessing safety and preliminary efficacy of EYE103 in patients with diabetic macular edema (DME) given as monotherapy o...

Enrolling

Diabetic Macular Edema (DME)

Neovascular Age-related Macular Degeneration (NVAMD)

Drug: EYE103

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

The purpose of this study is to learn how well efinopegdutide works compared to placebo in people who have non-alcoholic steatohepatitis (NASH). Rese...

Enrolling

Nonalcoholic Fatty Liver Disease

Fatty Liver, Nonalcoholic

Drug: Semaglutide

Drug: Placebo

A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD).

Enrolling

Alzheimer Disease

Drug: Donanemab

Drug: Placebo

A Study of MK-0616 (Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The primary...

Active, not recruiting

Hypercholesterolemia

Familial Hypercholesterolemia

Drug: MK-0616

Drug: Placebo

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

This is a two-part study designed to evaluate the effect of Estetrol (E4) 15 or 20 mg, or placebo on the severity and frequency of vasomotor symptoms...

Active, not recruiting

Menopausal Symptoms

Vasomotor Symptoms

Drug: Progesterone oral tablet

Drug: Estetrol oral tablet